Combination of bevacizumab (A) and pegylated-liposomal doxorubicin (PLD) (PLD-A) in sarcoma (SAR).

被引:0
|
作者
Haddad, P. A.
Skubitz, K. M.
机构
[1] LSU Hlth Sci Ctr, Shreveport, LA USA
[2] Univ Minnesota, Minneapolis, MN 55455 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9556
引用
收藏
页码:533S / 533S
页数:1
相关论文
共 50 条
  • [1] Combination of pegylated-liposomal doxorubicin (PLD) and bevacizumab (B) (PLD-B) in sarcoma (SAR)
    Skubitz, K. M.
    Haddad, P. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
    Robert T. O’Donnell
    Shiloh M. Martin
    Yunpeng Ma
    William C. Zamboni
    Joseph M. Tuscano
    Investigational New Drugs, 2010, 28 : 260 - 267
  • [3] Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
    O'Donnell, Robert T.
    Martin, Shiloh M.
    Ma, Yunpeng
    Zamboni, William C.
    Tuscano, Joseph M.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (03) : 260 - 267
  • [4] Intrahepatic pegylated liposomal doxorubicin (PLD) in patients with liver malignancies
    Granetto, C.
    Fea, E.
    Colantonio, I
    Di Costanzo, G.
    Garrone, O.
    Gasco, M.
    Occelli, M.
    Heouaine, A.
    Numico, G.
    Merlano, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 32 - 32
  • [5] Pegylated Liposomal Doxorubicin (PLD) in the treatment of advanced Cutaneous Lymphomas
    Cantonetti, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : S14 - S14
  • [6] Role of pegylated liposomal doxorubicin (PLD) in epithelial ovarian cancer
    Lorusso, D
    Ferrandina, G
    Lo Voi, R
    Fagotti, A
    Scambia, G
    JOURNAL OF CHEMOTHERAPY, 2004, 16 : 98 - 103
  • [7] Phase II trial of pegylated-liposomal doxorubicin (Doxil™) in sarcoma
    Skubitz, KM
    CANCER INVESTIGATION, 2003, 21 (02) : 167 - 176
  • [8] Phase Ib study of RAD001 (R) with pegylated-liposomal doxorubicin (PLD) in patients with advanced solid tumors
    Perotti, A.
    Sessa, C.
    Colombo, N.
    Del Conte, G.
    Delmonte, A.
    Diena, T.
    Lapresa, M.
    Parma, G.
    Vigano, L.
    Gianni, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)
    Sanchez Henarejos, Pilar
    Ros Martinez, Silverio
    Marin Zafra, Gema R.
    Alonso Romero, Jose L.
    Navarrete Montoya, Agustin
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (07): : 486 - 487
  • [10] Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)
    Pilar Sánchez Henarejos
    Silverio Ros Martínez
    Gema R. Marín Zafra
    José L. Alonso Romero
    Agustín Navarrete Montoya
    Clinical and Translational Oncology, 2009, 11 : 486 - 487